ArticleGynecologic oncology reports2026
Pembrolizumab-based systemic therapy associated with opportunities for subsequent local treatment in advanced or recurrent neuroendocrine carcinoma of the cervix: a five-case series.
Naoyuki Ida et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.